ClinicalTrials.gov (NCT02235961) Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects. U.S. National Institutes of Health.
